Hyperlipidaemia

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
2 Unique IMPs
1 Commercial trials
Drug classes (ATC)
C Cardiology (ATC C) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Statin 1 substance
Phase III/IV: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase III/IV

1 trial
  • KRKA tovarna zdravil d.d. Novo mesto Commercial
    EZETIMIBE, ROSUVASTATIN; ROSUVASTATIN
    2023-504914-31-00 5 countries 2024 n=195
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
KRKA tovarna zdravil d.d. Novo mesto Commercial 1 Phase III/IV 0
New trials by year
2024
1
← All indication landscapes